TAMPELLINI, MARCO
TAMPELLINI, MARCO
ONCOLOGIA
A case of long-term survival after repeated response to oxaliplatin-based chemotherapy and repeated thermoablation of liver metastases from colorectal cancer. Should we introduce the concept of oxaliplatin-resistant tumors?
2013-01-01 Ottone A; Bellini E; Ferrero A; Baratelli C; Taberna E; Bitossi R; Brizzi MP; Tampellini M
A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients
2018-01-01 Baratelli, Chiara; Zichi, Clizia; Di Maio, Massimo*; Brizzi, Maria Pia; Sonetto, Cristina; Scagliotti, Giorgio Vittorio; Tampellini, Marco
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma
2009-01-01 Brizzi MP; Sculli CM; Ragni F; Porpiglia F; Tampellini M; Gorzegno G; Priola AM; Dogliotti L; Berruti A.
Acute and fatal thrombocytopenic thrombotic purpura after a single dose of pemetrexed
2014-01-01 Irene Alabiso;Chiara Baratelli;Maria Pia Brizzi;Raffaella Bitossi;Azzurra Ottone;Marco Tampellini
Aggiornamenti in Cronochemioterapia
2004-01-01 Dogliotti L; Tampellini M; Angeli A
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions
2016-01-01 Tampellini, Marco; Benedetto, Simone; Rubatto, Elena; Baratelli, Chiara; DI Scipio, Federica; Pirro, Elisa; Brizzi, Maria Pia; Sonetto, Cristina; DI Maio, Massimo; Berta, Giovanni Nicolao; Scagliotti, Giorgio Vittorio
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome
2008-01-01 A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti
Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy
2016-01-01 Tampellini, Marco; Gned, Dario; Baratelli, Chiara; Brizzi, Maria Pia; Ottone, Azzurra; Alabiso, Irene; Bertaggia, Chiara; Di Maio, Massimo; Scagliotti, Giorgio Vittorio; Veltri, Andrea
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.
2008-01-01 Generali D; Dovio A; Tampellini M; Tucci M; Tedoldi S; Torta M; Bonardi S; Allevi G; Aguggini S; Milani M; Harris AL; Bottini A; Dogliotti L; Angeli A; Berruti A.
Chirurgia delle metastasi polmonari da carcinoma colo-rettale: una serie di 171 pazienti.
2014-01-01 Luca Errico; Elena Lisi; Elena Asteggiano; Matteo Gagliasso; Nicola Liberato; Corrado Novello; Marco Tampellini; Francesco Ardissone
Chronomodulated delivery schedule of Oxaliplatin (OHP), 5-Fluorouracil and Folinic Acid (FFL4/10) allows to increase significantly dose intensity rate of OHP based schedule: 2 years experience in gastrointestinal cancers
2004-01-01 Masseroni S; Pirovano M; Nasisi A; Biffi A; Romanelli A; Sestini S; Valsecchi R; Martignoni G; Tabiadon D; Tampellini M
Circadian changes in mitoxantrone toxicity in mice: relationship with plasma pharmacokinetics.
1994-01-01 LÉVI F ;TAMPELLINI M ;METZGER G ;BIZI E ;LEMAIGRE G ;HALLEK M
Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer
2009-01-01 Innominato PF; Focan C; Gorlia T; Moreau T; Garufi C; Waterhouse J; Giacchetti S; Coudert B; Iacobelli S; Genet D; Tampellini M; Chollet P; Lentz MA; Mormont MC; Lévi F; Bjarnason GA
Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects
2005-01-01 D. G. Generali; S. Tedoldi; M. Tampellini; A. Berruti; M. Torta; S. Bonardi; A. Bottini; M. Tucci; M. Milani; A. Angeli; L. Dogliotti
CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS
2004-01-01 Daniele Generali; Sara Tedoldi; Alberto Bottini; Alfredo Berruti; Marco Tampellini; Marcello Tucci; Giovanni Allevi; Mirella Torta; Simone Bonardi; Manuela Milani; Sergio Aguggini; Alberto Angeli; Luigi Dogliotti
Circadian rhythm of breakthrough cancer pain.
2011-01-01 A. Saini; M. Tucci; K. Bouraouia; P. Ghio; M. Tampellini; P. M. Furlan; L. Ostacoli; L. Dogliotti; A. Berruti
Circadian variation of breakthrough pain in cancer patients.
2013-01-01 Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy
2015-01-01 Tampellini, M; Polverari, R.S.; Ottone, A.; Alabiso, I.; Baratelli, C.; Bitossi, R.; Brizzi, M.P.; Leone, F.; Forti, L.; Bertona, E.; Racca, P.; Mecca, C.; Alabiso, O.; Aglietta, M.; Berruti, A.; Scagliotti, G.V.
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma
2017-01-01 Cusato, Jessica; DE FRANCIA, Silvia; Allegra, Sarah; Carrella, Simona; Pirro, Elisa; Piccione, Francesca Maria; De Martino, Francesca; Ferrero, Anna; Daffara, Fulvia Claudia; Terzolo, Massimo; Berruti, Alfredo; DI CARLO, Francesco; Tampellini, Marco; D'Avolio, Antonio
Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience.
2001-01-01 STIVANELLO M; A. BERRUTI; TORTA M; TERMINE A; TAMPELLINI M; GORZEGNO G; ANGELI A; DOGLIOTTI L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case of long-term survival after repeated response to oxaliplatin-based chemotherapy and repeated thermoablation of liver metastases from colorectal cancer. Should we introduce the concept of oxaliplatin-resistant tumors? | 2013 | Ottone A; Bellini E; Ferrero A; Baratelli C; Taberna E; Bitossi R; Brizzi MP; Tampellini M | |
| A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients | 2018 | Baratelli, Chiara; Zichi, Clizia; Di Maio, Massimo*; Brizzi, Maria Pia; Sonetto, Cristina; Scagliotti, Giorgio Vittorio; Tampellini, Marco | |
| Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma | 2009 | Brizzi MP; Sculli CM; Ragni F; Porpiglia F; Tampellini M; Gorzegno G; Priola AM; Dogliotti L; Berruti A. | |
| Acute and fatal thrombocytopenic thrombotic purpura after a single dose of pemetrexed | 2014 | Irene Alabiso;Chiara Baratelli;Maria Pia Brizzi;Raffaella Bitossi;Azzurra Ottone;Marco Tampellini | |
| Aggiornamenti in Cronochemioterapia | 2004 | Dogliotti L; Tampellini M; Angeli A | |
| Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions | 2016 | Tampellini, Marco; Benedetto, Simone; Rubatto, Elena; Baratelli, Chiara; DI Scipio, Federica; Pirro, Elisa; Brizzi, Maria Pia; Sonetto, Cristina; DI Maio, Massimo; Berta, Giovanni Nicolao; Scagliotti, Giorgio Vittorio | |
| Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome | 2008 | A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti | |
| Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy | 2016 | Tampellini, Marco; Gned, Dario; Baratelli, Chiara; Brizzi, Maria Pia; Ottone, Azzurra; Alabiso, Irene; Bertaggia, Chiara; Di Maio, Massimo; Scagliotti, Giorgio Vittorio; Veltri, Andrea | |
| Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. | 2008 | Generali D; Dovio A; Tampellini M; Tucci M; Tedoldi S; Torta M; Bonardi S; Allevi G; Aguggini S; Milani M; Harris AL; Bottini A; Dogliotti L; Angeli A; Berruti A. | |
| Chirurgia delle metastasi polmonari da carcinoma colo-rettale: una serie di 171 pazienti. | 2014 | Luca Errico; Elena Lisi; Elena Asteggiano; Matteo Gagliasso; Nicola Liberato; Corrado Novello; Marco Tampellini; Francesco Ardissone | |
| Chronomodulated delivery schedule of Oxaliplatin (OHP), 5-Fluorouracil and Folinic Acid (FFL4/10) allows to increase significantly dose intensity rate of OHP based schedule: 2 years experience in gastrointestinal cancers | 2004 | Masseroni S; Pirovano M; Nasisi A; Biffi A; Romanelli A; Sestini S; Valsecchi R; Martignoni G; Tabiadon D; Tampellini M | |
| Circadian changes in mitoxantrone toxicity in mice: relationship with plasma pharmacokinetics. | 1994 | LÉVI F ;TAMPELLINI M ;METZGER G ;BIZI E ;LEMAIGRE G ;HALLEK M | |
| Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer | 2009 | Innominato PF; Focan C; Gorlia T; Moreau T; Garufi C; Waterhouse J; Giacchetti S; Coudert B; Iacobelli S; Genet D; Tampellini M; Chollet P; Lentz MA; Mormont MC; Lévi F; Bjarnason GA | |
| Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects | 2005 | D. G. Generali; S. Tedoldi; M. Tampellini; A. Berruti; M. Torta; S. Bonardi; A. Bottini; M. Tucci; M. Milani; A. Angeli; L. Dogliotti | |
| CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS | 2004 | Daniele Generali; Sara Tedoldi; Alberto Bottini; Alfredo Berruti; Marco Tampellini; Marcello Tucci; Giovanni Allevi; Mirella Torta; Simone Bonardi; Manuela Milani; Sergio Aguggini; Alberto Angeli; Luigi Dogliotti | |
| Circadian rhythm of breakthrough cancer pain. | 2011 | A. Saini; M. Tucci; K. Bouraouia; P. Ghio; M. Tampellini; P. M. Furlan; L. Ostacoli; L. Dogliotti; A. Berruti | |
| Circadian variation of breakthrough pain in cancer patients. | 2013 | Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A | |
| Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy | 2015 | Tampellini, M; Polverari, R.S.; Ottone, A.; Alabiso, I.; Baratelli, C.; Bitossi, R.; Brizzi, M.P.; Leone, F.; Forti, L.; Bertona, E.; Racca, P.; Mecca, C.; Alabiso, O.; Aglietta, M.; Berruti, A.; Scagliotti, G.V. | |
| Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma | 2017 | Cusato, Jessica; DE FRANCIA, Silvia; Allegra, Sarah; Carrella, Simona; Pirro, Elisa; Piccione, Francesca Maria; De Martino, Francesca; Ferrero, Anna; Daffara, Fulvia Claudia; Terzolo, Massimo; Berruti, Alfredo; DI CARLO, Francesco; Tampellini, Marco; D'Avolio, Antonio | |
| Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience. | 2001 | STIVANELLO M; A. BERRUTI; TORTA M; TERMINE A; TAMPELLINI M; GORZEGNO G; ANGELI A; DOGLIOTTI L |